Methods: 10733 women with a complete first trimester screening were included. Potential predictors for birth weight included maternal age, BMI, parity, smoking status, type of conception, time difference (days) between date of pregnancy based on CRL and LMP (CRL-LMP), uterine artery lowest PI (UtA-LPI), PAPP-A and bHCG (MoM) as well as abdominal circumference (AC, Z-score). Bootstrap methods were used for model selection and estimation, under an approximately uniform distribution of birth weight. A model was built to predict individual birthweight using first trimester variables. The additional value of these variables was quantified by comparing the birthweight absolute percent prediction error (APPE) given by the model to the percent error using the average weight reference provided by the Intergrowth study. Small and large for gestational age (SGA and LGA) were defined by birth weight <10th centile and >90th centile respectively. Results: The prediction model included BMI, parity, smoking status, time difference between date of pregnancy based on CRL and LMP, UtA-LPI, PAPP-A, bHCG and AC. in SGA newborns, first trimester individual birthweight predictions were significantly closer to the actual birthweight (median APPE=17% IQR=10-23) compared to population references (median APPE 24% IQR=20-30). However, in the overall population as in LGA newborns, first trimester did not improve birthweight prediction compared to the average weight reference. Conclusions: Birthweight predictions based on a combination of maternal history, ultrasound, and biochemistry in the first trimester significantly improved screening for SGA with a significant contribution of CRL-LMP.
Objectives:
To evaluate maternal hemodynamic profile in hypertensive or normotensive pregnancies complicated by intrauterine growth restriction (IUGR). Methods: 54 patients affected by hypertensive disorder of pregnancy (HDP: gestational hypertension, pre-eclampsia), between 24 and 40 gestational weeks, were recruited in this observational prospective study: 21 HDP with intrauterine growth restriction (HDP-IUGR), 14 normotensive women with severe IUGR (s-IUGR), 19 controls with uneventful pregnancies.
Diagnosis of HDP was made according to the criteria of the ISSHP. s-IUGR was defined as a fetus with abdominal circumference <5th centile and a Doppler velocimetry in umbilical artery >2SD.
Maternal echocardiography was performed in blind, by a dedicated cardiologist, to measure hemodynamic parameters (cardiac output CO, total vascular resistances TVR), indexes of systolic function (ejection fraction EF, systolic peak S-wave velocity S'), indexes of diastolic function evaluated at tissue Doppler (E'/A' and E/E' ratios) and indexes of cardiac remodelling (left ventricular mass LVM, relative wall thickness RWT). Results: CO was significantly reduced and TVR significantly increased in both HDP-IUGR and s-IUGR groups compared with controls, even if mean arterial pressure was significantly increased only in the HDP-IUGR group. Heart rate (HR) was significantly reduced only in the HDP-IUGR group. In both groups systolic function, diastolic function and cardiac remodelling indexes didn't show any significant difference compared with controls.
Conclusions: HDP-IUGR and s-IUGR groups show a similar hemodynamic profile, even if patients from the latter group are normotensive. The failed cardiovascular adaption to pregnancy denotes a common etiopathogenensis, based on early placental damage. Anti-hypertensive therapy, started as soon as blood pressure increases, may explain why our HDP-IUGR and s-IUGR patients don't develop a pathological concentric hypertrophy, otherwise described by other Authors. Objectives: To analyse the ventricular function in fetus with Ebstein's anomaly by velocity vector imaging, and to explore the correlation between the cardiac function and the blood flow across the pulmonary valve. Methods: We choose 26 EA fetus and 39 normal fetus with matching gestation weeks; then divide EA fetus into 2 groups according to the pulmonary valve flow direction, direct or reverse. We obtain the left and right ventricular myocardial long axis integral peak velocity, strain and strain rate by VVI, then compare in the group and between groups. Results: 1.Between groups: The right ventricular global longitudinal strain (GLS) and diastolic velocity in EA group is -13.16±5.31% and -1.86±0.55 cm/s, meanwhile in the normal group is -18.89±0.80% and -2.25±0.73 cm/s. The data in EA group are lower than the normal group, with significant difference(p<0.01).
OP02: FETAL CARDIAC FUNCTION

OP02.01 Evaluation of ventricular function in fetus with
Within group: The left ventricular GLS in EA fetus with pulmonary valve reverse flow is -22.60±5.13%, and in EA fetus with direct flow is -18.58±4.25%. The data in fetus with reverse flow are higher than the fetus with direct flow, with significant difference(p<0.05). Conclusions: The Ebstein's anomaly affect the fetal cardiac function significantly, with difference influence in varying degrees deformity. VVI can sensitively reflect the myocardial mechanics changes in EA fetus, especially the GLS and diastolic velocity with great sensitivity and specificity for myocardial function evaluation.
